相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncostatin M promotes hepatic progenitor cell activation and hepatocarcinogenesis via macrophage-derived tumor necrosis factor-α
Xue Yang et al.
CANCER LETTERS (2021)
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Roser Pinyol et al.
JOURNAL OF HEPATOLOGY (2021)
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
Beatrice Foglia et al.
CELLS (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M
Zhenjia Yu et al.
GASTRIC CANCER (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yoon Mee Yang et al.
SEMINARS IN LIVER DISEASE (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors-1α and-2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
Stefania Cannito et al.
CANCERS (2019)
Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice
Michitaka Matsuda et al.
HEPATOLOGY (2018)
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2018)
Hypoxia-inducible factor 2 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein
Elisabetta Morello et al.
HEPATOLOGY (2018)
Should we undertake surveillance for HCC in patients with NAFLD?
Ramy Younes et al.
JOURNAL OF HEPATOLOGY (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice
Danielle van Keulen et al.
PLOS ONE (2018)
Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Jacob M. Smigiel et al.
MOLECULAR CANCER RESEARCH (2017)
Oncostatin M: Potential Implications for Malignancy and Metabolism
Jacqueline M. Stephens et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival
Justyna A. Kucia-Tran et al.
BRITISH JOURNAL OF CANCER (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Chi Ma et al.
NATURE (2016)
The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells
Nadia Battello et al.
CANCER & METABOLISM (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis
Minjiao Zhu et al.
ONCOLOGY REPORTS (2015)
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Sanjaya K. Satapathy et al.
SEMINARS IN LIVER DISEASE (2015)
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells
Stefania Cannito et al.
ONCOTARGET (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
C. Turato et al.
BRITISH JOURNAL OF CANCER (2014)
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma
Maria M. Caffarel et al.
JOURNAL OF PATHOLOGY (2014)
Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer
N. R. West et al.
ONCOGENE (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Unraveling the influence of endothelial cell density on VEGF-A signaling
Lucia Napione et al.
BLOOD (2012)
Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73
Hongyan Liang et al.
CANCER BIOMARKERS (2012)
Nonalcoholic Steatohepatitis and Noncirrhotic Hepatocellular Carcinoma: Fertile Soil
Dawn M. Torres et al.
SEMINARS IN LIVER DISEASE (2012)
Exploring Genomic Profiles of Hepatocellular Carcinoma
Hyun Goo Woo et al.
MOLECULAR CARCINOGENESIS (2011)
SERPINB3 induces epithelial-mesenchymal transition
Santina Quarta et al.
JOURNAL OF PATHOLOGY (2010)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
Hypoxia-Inducible Factor 1α Is Up-Regulated by Oncostatin M and Participates in Oncostatin M Signaling
Stefan Vollmer et al.
HEPATOLOGY (2009)
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
Stefania Cannito et al.
CARCINOGENESIS (2008)
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression
Aristidis Moustakas et al.
CANCER SCIENCE (2007)
Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells
Cheryl L. Jorcyk et al.
CYTOKINE (2006)
Angiogenesis: The VE-cadherin switch
Y Wallez et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases
I Boing et al.
CELLULAR SIGNALLING (2006)
Expression of oncostatin M and its receptors in normal and cirrhotic human liver
I Znoyko et al.
JOURNAL OF HEPATOLOGY (2005)
Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells
E Audero et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
VEGF-receptor signal transduction
MJ Cross et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
M Morales-Ruiz et al.
CIRCULATION RESEARCH (2000)
分享论文
